ARTICLE | Company News
Pisgah Labs drug delivery news
January 7, 2013 8:00 AM UTC
On Dec. 20, 2012, Pisgah said the U.S. Patent and Trademark Office issued U.S. Patent No. 8,334,322, which covers abuse-deterrent forms of pseudoephedrine and ephedrine and expires in December 2029. P...